Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 1956104, 13 pages
https://doi.org/10.1155/2017/1956104
Research Article

Protective Effects of Oral Astaxanthin Nanopowder against Ultraviolet-Induced Photokeratitis in Mice

1Division of Oral Medicine and Pathology, Department of Human Biology and Pathophysiology, School of Dentistry, Health Sciences University of Hokkaido, Tobetsu, Japan
2School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan
3Department of Ophthalmology, Institute for Clinical and Experimental Medicine, Linkoping University, Linkoping, Sweden
4Laboratory of Biomedical Cell Technologies, School of Biomedicine, Far Eastern Federal University, Vladivostok, Russia
5Division of Disease Control and Molecular Epidemiology, Department of Oral Growth and Development, School of Dentistry, Health Sciences University of Hokkaido, Tobetsu, Japan
6The Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido, Tobetsu, Japan
7Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
8Health Care Laboratory, FUJIFILM Corporation, Tokyo, Japan
9Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan
10Department of Dentistry, Lotung Poh-Ai Hospital, Yilan, Taiwan
11Department of Ophthalmology, Health Sciences University of Hokkaido Hospital, Sapporo, Japan

Correspondence should be addressed to Nobuyoshi Kitaichi; pj.ca.u-oyri-ukoh@atikubon

Received 2 April 2017; Revised 14 June 2017; Accepted 25 July 2017; Published 28 September 2017

Academic Editor: Xiaolun Sun

Copyright © 2017 Fumiya Harada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. D. Schein, “Phototoxicity and the cornea,” Journal of the National Medical Association, vol. 84, no. 7, pp. 579–583, 1992. View at Google Scholar
  2. A. P. Cullen, B. R. Chou, M. G. Hall, and S. E. Jany, “Ultraviolet-B damages corneal endothelium,” American Journal of Optometry and Physiological Optics, vol. 61, no. 7, pp. 473–478, 1984. View at Publisher · View at Google Scholar
  3. N. Kitaichi, T. Shimizu, K. Yoshida et al., “Macrophage migration inhibitory factor ameliorates UV-induced photokeratitis in mice,” Experimental Eye Research, vol. 86, no. 6, pp. 929–935, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. G. Fassett and J. S. Coombes, “Astaxanthin, oxidative stress, inflammation and cardiovascular disease,” Future Cardiology, vol. 5, no. 4, pp. 333–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Jyonouchi, S. Sun, Y. Tomita, and M. D. Gross, “Astaxanthin, a carotenoid without vitamin A activity, augments antibody responses in cultures including T-helper cell clones and suboptimal doses of antigen,” The Journal of Nutrition, vol. 125, no. 10, pp. 2483–2492, 1995. View at Google Scholar
  6. M. Kobayashi, “In vivo antioxidant role of astaxanthin under oxidative stress in the green alga Haematococcus pluvialis,” Applied Microbiology and Biotechnology, vol. 54, no. 4, pp. 550–555, 2000. View at Publisher · View at Google Scholar
  7. B. P. Chew, J. S. Park, M. W. Wong, and T. S. Wong, “A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo,” Anticancer Research, vol. 19, no. 3A, pp. 1849–1853, 1999. View at Google Scholar
  8. M. Ikeuchi, T. Koyama, J. Takahashi, and K. Yazawa, “Effects of astaxanthin in obese mice fed a high-fat diet,” Bioscience, Biotechnology, and Biochemistry, vol. 71, no. 4, pp. 893–899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. F. J. Pashkow, D. G. Watumull, and C. L. Campbell, “Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease,” The American Journal of Cardiology, vol. 101, no. 10A, pp. 58D–68D, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. T. Chen and K. Kotani, “Astaxanthin as a potential protector of liver function: a review,” Journal of Clinical Medicine Research, vol. 8, no. 10, pp. 701–704, 2016. View at Publisher · View at Google Scholar
  11. M. Kaneko, Y. Kishimoto, R. Suzuki, Y. Kawai, I. Tateya, and S. Hirano, “Protective effect of astaxanthin on vocal fold injury and inflammation due to vocal loading: a clinical trial,” Journal of Voice, vol. 31, no. 3, pp. 352–358, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Mortensen, L. H. Skibsted, J. Sampson, C. Rice-Evans, and S. A. Everett, “Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidants,” FEBS Letters, vol. 418, no. 1-2, pp. 91–97, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Yoshihisa, M. U. Rehman, and T. Shimizu, “Astaxanthin, a xanthophyll carotenoid, inhibits ultraviolet-induced apoptosis in keratinocytes,” Experimental Dermatology, vol. 23, no. 3, pp. 178–183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Y. Dong, J. Jin, G. Lu, and X. L. Kang, “Astaxanthin attenuates the apoptosis of retinal ganglion cells in db/db mice by inhibition of oxidative stress,” Marine Drugs, vol. 11, no. 3, pp. 960–974, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Otsuka, M. Shimazawa, T. Nakanishi et al., “Protective effects of a dietary carotenoid, astaxanthin, against light-induced retinal damage,” Journal of Pharmacological Sciences, vol. 123, no. 3, pp. 209–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. P. T. Yeh, H. W. Huang, C. M. Yang, W. S. Yang, and C. H. Yang, “Astaxanthin inhibits expression of retinal oxidative stress and inflammatory mediators in streptozotocin-induced diabetic rats,” PLoS One, vol. 11, no. 1, article e0146438, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Otsuka, M. Shimazawa, Y. Inoue et al., “Astaxanthin protects against retinal damage: evidence from in vivo and in vitro retinal ischemia and reperfusion models,” Current Eye Research, vol. 41, no. 11, pp. 1465–1472, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Yamagishi and M. Aihara, “Neuroprotective effect of astaxanthin against rat retinal ganglion cell death under various stresses that induce apoptosis and necrosis,” Molecular Vision, vol. 20, pp. 1796–1805, 2014. View at Google Scholar
  19. H. Hashimoto, K. Arai, S. Hayashi et al., “Effects of astaxanthin on antioxidation in human aqueous humor,” Journal of Clinical Biochemistry and Nutrition, vol. 53, no. 1, pp. 1–7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Riccioni, N. D'Orazio, S. Franceschelli, and L. Speranza, “Marine carotenoids and cardiovascular risk markers,” Marine Drugs, vol. 9, no. 7, pp. 1166–1175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. R. Ambati, S. M. Phang, S. Ravi, and R. G. Aswathanarayana, “Astaxanthin: sources, extraction, stability, biological activities and its commercial applications—a review,” Marine Drugs, vol. 12, no. 1, pp. 128–152, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. R. Meor Mohd Affandi, T. Julianto, and A. B. A. Majeed, “Development and stability evaluation of astaxanthin nanoemulsion,” Asian Journal of Pharmaceutical and Clinical Research, vol. 4, Supplement 1, pp. 143–148, 2011. View at Google Scholar
  23. M. Ogawa, M. Sato, and K. Suzuki, “Development of astaxanthin nano emulsion with improved shelf life and enhanced absorbability,” FUJI Film Research & Development, vol. 52, no. 2007, pp. 26–29, 2007. View at Google Scholar
  24. K. Ohgami, K. Shiratori, S. Kotake et al., “Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo,” Investigative Ophthalmology & Visual Science, vol. 44, no. 6, pp. 2694–2701, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Izumi-Nagai, N. Nagai, K. Ohgami et al., “Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin,” Investigative Ophthalmology & Visual Science, vol. 49, no. 4, pp. 1679–1685, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Suzuki, K. Ohgami, K. Shiratori et al., “Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway,” Experimental Eye Research, vol. 82, no. 2, pp. 275–281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. E. R. Muth, J. M. Laurent, and P. Jasper, “The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity,” Alternative Medicine Review, vol. 5, no. 2, pp. 164–173, 2000. View at Google Scholar
  28. N. I. Krinsky, J. T. Landrum, and R. A. Bone, “Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye,” Annual Review of Nutrition, vol. 23, pp. 171–201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. N. K. Scripsema, D. N. Hu, and R. B. Rosen, “Lutein, zeaxanthin, and meso-zeaxanthin in the clinical management of eye disease,” Journal of Ophthalmology, vol. 2015, Article ID 865179, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Lennikov, N. Kitaichi, K. Noda et al., “Amelioration of endotoxin-induced uveitis treated with an IkappaB kinase beta inhibitor in rats,” Molecular Vision, vol. 18, pp. 2586–2597, 2012. View at Google Scholar
  31. I. Yamakawa, H. Kojima, T. Terashima et al., “Inactivation of TNF-alpha ameliorates diabetic neuropathy in mice,” American Journal of Physiology. Endocrinology and Metabolism, vol. 301, no. 5, pp. E844–E852, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. A. Marchitti, Y. Chen, D. C. Thompson, and V. Vasiliou, “Ultraviolet radiation: cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes,” Eye & Contact Lens, vol. 37, no. 4, pp. 206–213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. D. E. Heck, A. M. Vetrano, T. M. Mariano, and J. D. Laskin, “UVB light stimulates production of reactive oxygen species: unexpected role for catalase,” The Journal of Biological Chemistry, vol. 278, no. 25, pp. 22432–22436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. W. P. Roos and B. Kaina, “DNA damage-induced cell death by apoptosis,” Trends in Molecular Medicine, vol. 12, no. 9, pp. 440–450, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Yamamoto and R. B. Gaynor, “Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer,” The Journal of Clinical Investigation, vol. 107, no. 2, pp. 135–142, 2001. View at Publisher · View at Google Scholar
  36. A. Hoffmann, A. Levchenko, M. L. Scott, and D. Baltimore, “The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation,” Science, vol. 298, no. 5596, pp. 1241–1245, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. K. D. Cooper, N. Duraiswamy, C. Hammerberg et al., “Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury,” The Journal of Investigative Dermatology, vol. 101, no. 2, pp. 155–163, 1993. View at Publisher · View at Google Scholar
  38. A. Lennikov, N. Kitaichi, R. Fukase et al., “Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops,” Molecular Vision, vol. 18, pp. 455–464, 2012. View at Google Scholar
  39. R. L. Roberts, J. Green, and B. Lewis, “Lutein and zeaxanthin in eye and skin health,” Clinics in Dermatology, vol. 27, no. 2, pp. 195–201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. P. S. Bernstein, M. D. Yoshida, N. B. Katz, R. W. McClane, and W. Gellermann, “Raman detection of macular carotenoid pigments in intact human retina,” Investigative Ophthalmology & Visual Science, vol. 39, no. 11, pp. 2003–2011, 1998. View at Google Scholar
  41. J. T. Landrum, R. A. Bone, and M. D. Kilburn, “The macular pigment: a possible role in protection from age-related macular degeneration,” Advances in Pharmacology, vol. 38, pp. 537–556, 1997. View at Google Scholar
  42. P. Palozza, S. Serini, F. Nicuolo, and G. Calviello, “Modulation of apoptotic signalling by carotenoids in cancer cells,” Archives of Biochemistry and Biophysics, vol. 430, no. 1, pp. 104–109, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. E. R. Sindhu, K. C. Preethi, and R. Kuttan, “Antioxidant activity of carotenoid lutein in vitro and in vivo,” Indian Journal of Experimental Biology, vol. 48, no. 8, pp. 843–848, 2010. View at Google Scholar
  44. E. Kotake-Nara and A. Nagao, “Absorption and metabolism of xanthophylls,” Marine Drugs, vol. 9, no. 6, pp. 1024–1037, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Czank, A. Cassidy, Q. Zhang et al., “Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study,” The American Journal of Clinical Nutrition, vol. 97, no. 5, pp. 995–1003, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy, “Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies,” The American Journal of Clinical Nutrition, vol. 81, Supplement 1, pp. 230S–242S, 2005. View at Google Scholar
  47. G. Williamson and C. Manach, “Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies,” The American Journal of Clinical Nutrition, vol. 81, Supplement 1, pp. 243S–255S, 2005. View at Google Scholar
  48. A. Ferencz, B. Racz, B. Gasz, K. Kalmar-Nagy, O. P. Horvath, and E. Roth, “Threshold level of NF-kB activation in small bowel ischemic preconditioning procedure,” Transplantation Proceedings, vol. 38, no. 6, pp. 1800–1802, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Bhuvaneswari, B. Yogalakshmi, S. Sreeja, and C. V. Anuradha, “Astaxanthin reduces hepatic endoplasmic reticulum stress and nuclear factor-kappaB-mediated inflammation in high fructose and high fat diet-fed mice,” Cell Stress & Chaperones, vol. 19, no. 2, pp. 183–191, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Terazawa, H. Nakajima, M. Shingo, T. Niwano, and G. Imokawa, “Astaxanthin attenuates the UVB-induced secretion of prostaglandin E2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletion-independent manner,” Experimental Dermatology, vol. 21, Supplement 1, pp. 11–17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Petri and A. K. Lundebye, “Tissue distribution of astaxanthin in rats following exposure to graded levels in the feed,” Comparative Biochemistry and Physiology Part C: Toxicology Pharmacology, vol. 145, no. 2, pp. 202–209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. J. L. Alio, M. J. Ayala, M. E. Mulet, A. Artola, J. M. Ruiz, and J. Bellot, “Antioxidant therapy in the treatment of experimental acute corneal inflammation,” Ophthalmic Research, vol. 27, no. 3, pp. 136–143, 1995. View at Publisher · View at Google Scholar
  53. E. Arnal, C. Peris-Martinez, J. L. Menezo, S. Johnsen-Soriano, and F. J. Romero, “Oxidative stress in keratoconus?” Investigative Ophthalmology & Visual Science, vol. 52, no. 12, pp. 8592–8597, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Buddi, B. Lin, S. R. Atilano, N. C. Zorapapel, M. C. Kenney, and D. J. Brown, “Evidence of oxidative stress in human corneal diseases,” The Journal of Histochemistry and Cytochemistry, vol. 50, no. 3, pp. 341–351, 2002. View at Publisher · View at Google Scholar